Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pay now or pay later: new report sheds light on the economic impact of osteoporosis in the workplace

Nov. 12, 2002

Japanese patent covers novel alpha2-adrenoceptor antagonists designed by Fuso scientists

Nov. 12, 2002

AstraZeneca announces trade name Galida for its investigational drug tesaglitazar

Nov. 11, 2002

Crestor receives first approval in Europe

Nov. 11, 2002

New data on the efficacy of darbepoetin alfa in cancer-related anemia

Nov. 11, 2002

Compounds for increasing GLP-1 blood levels designed at Banyu

Nov. 11, 2002

Novel cathepsin K inhibitors with utility in osteoporosis

Nov. 11, 2002

Pharmacopeia researchers design novel FSH modulators

Nov. 8, 2002

OGT-923 enters clinical testing

Nov. 7, 2002

Novo Nordisk submits marketing application for insulin detemir

Nov. 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...